Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-05-29
1991-10-08
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546171, 546172, C07D21516, A61K 3147
Patent
active
050554735
ABSTRACT:
A series of novel N-alkyl-N-(alkanesulphonamidoheterocyclicmethyl) -4-alkanesulphonamidophenethylamines have been prepared, including their pharmaceutically acceptable salts and various key novel intermediates therefor. The heterocyclic moiety present in these compounds is a benzo-fused heterocyclic group derived from either benzofuran, benzothiophene, benzoxazole or quinoline, and it is attached to the adjacent methyl group of the molecule by means of the available ring carbon atom which is situated alpha to the hetero atom. These particular compounds are useful in therapy as highly effective anti-arrhythmic agents and therefore, are of value in the treatment of various cardiac arrhythmias. Preferred member compounds include N-methyl-N-(5-methanesulphonamidobenzofur-2-ylmethyl)-4 -methanesulphonamidophenethylamine and N-methyl-N-(6- methanesulphonamidoquinol-2-ylmethyl)-4-methane-sulphonamidophenethylamine . Methods for preparing all these compounds from known starting materials are provided.
REFERENCES:
patent: 4485112 (1984-11-01), Pestellini et al.
patent: 4581367 (1986-04-01), Schromm et al.
patent: 4581457 (1986-04-01), Musser et al.
patent: 4803219 (1989-02-01), Combourieu et al.
patent: 4806536 (1989-02-01), Cross et al.
patent: 4863948 (1989-09-01), Arrowsmith et al.
C. Goldenberg et al., in Abstract No. 115384b of Chemical Abstracts, vol. 79, No. 19 (1973).
S. Kato et al., in Abstract No. 226336n of Chemical Abstracts, vol. 105, No. 25, p. 768 (1986).
Arrowsmith John E.
Cross Peter E.
Thomas Geoffrey N.
Ginsburg Paul H.
Pfizer Inc.
Richardson Peter C.
Springer David B.
LandOfFree
Quinolinyl sulfonamide anti-arrhythmic agents and use thereas does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinolinyl sulfonamide anti-arrhythmic agents and use thereas, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolinyl sulfonamide anti-arrhythmic agents and use thereas will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-257241